Lenzing's 8.65 Euro Subscription Price Triggers Sell-Off as Rights Trading Looms

Lenzing's subscription rights begin trading as the fibre maker raises about €300 million at €8.65 per share, a 42.5% discount to the ex-rights value.

The separation of subscription rights from Lenzing's ordinary shares on the Vienna Stock Exchange marks the start of a decisive phase for the fibre producer's shareholders. At the heart of the transaction lies the issuance of 34,756,362 new shares at a subscription price of 8.65 euros — a 42.5 percent discount to the theoretical ex-rights value. The market wasted little time responding: the stock shed 6.2 percent on Thursday and closed at 19.42 euros.

That gap between the market price and the issue price forces investors to actively manage their positions to avoid dilution losses. The subscription ratio of ten to nine means existing shareholders must hold ten old shares to subscribe for nine new ones, and the coming weeks will hinge on the market price of the subscription rights themselves. Whether long-standing shareholders can offset at least part of the decline in their holdings depends on what those rights fetch in trading.

A Fully Backed Deal With a 300 Million Euro Target

Gross proceeds are expected to reach roughly 300 million euros, earmarked for the "Grow Nonwovens, Reset Textiles" realignment and for restoring balance-sheet stability. The transaction carries an unusually solid backstop: it is fully guaranteed, with core anchor shareholders having already made binding commitments. Both the B&C Group and Brazilian partner Suzano have irrevocably pledged to exercise all subscription rights due to them, and Oberbank has likewise committed to exercising its rights.

Should the cash inflow materialise as planned, Lenzing's equity profile would improve markedly, giving the company the operational room it needs to reposition its ailing textile business and push ahead with the higher-margin nonwovens segment. For optimists, the move offers a clean break — a strengthened balance sheet and secured liquidity from which to navigate deep industry change.

The Dilution Arithmetic Cuts Both Ways

Set against that stands substantial dilution for any shareholder unable or unwilling to participate. With the total number of outstanding shares nearly doubling through the new issue, the percentage stake held by existing investors falls sharply. Those who decline to put up fresh capital surrender significant voting power and a smaller share of future earnings.

Sustained selling pressure is a further risk. If shareholders attempt to offload their subscription rights in large volumes, the price of those rights themselves could tumble — and such a downtrend would weigh on the ordinary shares too, should market participants move to exploit price differences between the old stock, the rights and the new shares. The macroeconomic backdrop for the fibre industry also remains demanding. Even a smooth completion of the recapitalisation does not guarantee an operational turnaround if demand in core textile markets stays subdued for an extended period.

Margins, Cost Cuts and the 20 to 25 Percent Hurdle

What ultimately matters for how the market values Lenzing is one fundamental target: achieving an operating margin of 20 to 25 percent before interest, taxes and depreciation. That medium-term profitability goal sits at the centre of the strategic overhaul. The group intends to retreat largely from unprofitable standard fibres and concentrate capacity on high-margin specialty fibres, premium Tencel-branded textiles and nonwovens.

At the same time, the cost base is to fall by 120 million euros versus 2025 levels, lifting operating earnings by 150 million euros over the medium term. Management is also targeting a reduction in net debt to below 2.5 times EBITDA. For investors, this savings and efficiency programme is the yardstick for the coming quarters — miss those targets, and the balance-sheet relief from the new equity would evaporate without permanently fixing the structural earnings weakness in the core business.

Financing Secured Through 2030, but Execution Risks Mount

The financial framework for the transition extends beyond the equity raise. Alongside the 300 million euros from the share issuance, Lenzing has secured up to 300 million euros in new financing, while existing credit lines have been extended through 2030 — giving the company the time it needs to push through the restructuring without acute liquidity strain. Operationally, a sharper focus on sustainable cellulose specialties and biorefinery products promises far more robust returns than the low-margin mass business. Partnerships such as the collaboration with ChemEx World on functional textiles based on Tencel technologies illustrate the potential in higher-margin territory. A successful sale of the Purwakarta site would bring in additional liquid funds and could see the group emerge stronger from its slimming-down.

The risks, however, are substantial. The planned elimination of roughly 2,000 jobs worldwide and the closure of entire sites will weigh heavily on the organisation, with production at Grimsby in England set to end in late 2027. Unexpected delays to those closures, or above-average one-off costs for the workforce reduction, could eat into the intended savings. The Purwakarta divestment carries its own risk of protracted negotiations or disappointing proceeds. And should demand in the premium segment falter, the downtrend could resume — the stock has already fallen 24 percent over the past twelve months.

October's Calendar Sets the First Real Test

The next few trading sessions will determine which path prevails. As long as the share price holds well above the 8.65 euro subscription price, the economic incentive to exercise rights remains high; should sentiment turn and the quote drift toward that level, the rights trade could come under heavy selling pressure.

The provisional timetable is set. Subscription rights trading on the Vienna Stock Exchange runs from 6 to 14 October inclusive, while the subscription period for the new shares runs from 6 to 20 October inclusive. Settlement, delivery and the start of trading in the new shares are scheduled for 23 October, subject to registration of the capital increase in the commercial register. Only then will the market's lasting verdict on the reshaped ownership structure and recapitalised balance sheet become clear.